Category: Life Sciences
Global Life Sciences
-
High Throughput Screening (HTS)
... reach US$45.3 Billion by 2030, growing at a CAGR of 1.6% over the analysis period 2023-2030. HTS Consumables / Reagents, one of the segments analyzed in the report, is expected to record a 3.7% CAGR ... Read More
-
Computerized Physician Order Entry (CPOE) Systems
... the year 2023, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Integrated CPOE Systems, one of the segments analyzed in the report, is expected ... Read More
-
Global Pneumococcal Vaccine Market Size study, by Vaccine Type (Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine) by Product (Prevnar 13, Synflorix, Pneumovax 23, Vaxneuvance, Pneumosil, Other Products) by End-use (Public Sector, Private Sector) and Regional Forecasts 2022-2032
... 2022-2032 Global Pneumococcal Vaccine Market is valued approximately USD 8.07 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.21% over the forecast period 2024-2032. The Pneumococcal Vaccine ... Read More
-
Mesenchymal Stem Cells (MSC)
... reach US$10.6 Billion by 2030, growing at a CAGR of 12.2% over the analysis period 2023-2030. Bone Marrow-sourced MSC, one of the segments analyzed in the report, is expected to record a 13.1% CAGR and ... Read More
-
Predictive Diagnostics
... at a CAGR of 10.4% over the analysis period 2023-2030. The U.S. Market is Estimated at US$735.3 Million While China is Forecast to Grow at 9.7% CAGR The Predictive Diagnostics market in the U.S. is ... Read More
-
Advanced (3D/4D) Visualization Systems
... reach US$6.5 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. MRI Modality, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach ... Read More
-
Dental Consumables
... at a CAGR of 6.5% over the analysis period 2023-2030. Dental Restoration Consumables, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$15.9 Billion by the end ... Read More
-
Pain Management Devices
... by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Neurostimulation Devices, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$3.5 Billion by ... Read More
-
Worldwide Biotech July 2024
... an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry. Read More
-
Medical Fiber Optics
... by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Pure Silica Fiber, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$816.6 Million ... Read More
-
Cardiovascular Catheters
... at a CAGR of 6.5% over the analysis period 2023-2030. Cardiovascular Therapeutic Catheters, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$25.4 Billion by the end ... Read More
-
Arthroscopy Instruments
... at a CAGR of 6.9% over the analysis period 2023-2030. Arthroscopy Implants, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$5.8 Billion by the end of ... Read More
-
Blood Flow Measurement Devices
... reach US$1.2 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2023-2030. Ultrasonic Doppler, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach ... Read More
-
Imaging Agents
... at a CAGR of 4.5% over the analysis period 2023-2030. Diagnostic Radiopharmaceuticals, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$7.2 Billion by the end of ... Read More
-
Medical Lighting Technologies
... by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Surgical Lighting Systems, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$5.2 Billion ... Read More
-
Medical Oxygen Systems
... by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Compressed Oxygen Cylinders, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.9 Billion ... Read More
-
Immunoassay Systems
... at a CAGR of 3.7% over the analysis period 2023-2030. Immunoassay Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$19.4 Billion by the ... Read More
-
Cell and Tissue Culture Supplies
... is expected to reach US$42.5 Billion by 2030, growing at a CAGR of 9.6% over the analysis period 2023-2030. Cell and Tissue Culture Consumables, one of the segments analyzed in the report, is expected to ... Read More
-
Computer Aided Detection (CAD)
... reach US$2.0 Billion by 2030, growing at a CAGR of 9.1% over the analysis period 2023-2030. Mammography Modality, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach ... Read More
-
Research ELISA (Enzyme-Linked Immunosorbent Assay)
... is expected to reach US$692.3 Million by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. ELISA Kits, one of the segments analyzed in the report, is expected to record a 3.5% ... Read More
-
Gastrointestinal (GI) Endoscopy Devices
... reach US$49.9 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), one of the segments analyzed in the report, is expected to record a 5.3% ... Read More
-
Organ Preservation Solutions
... by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Static Cold Storage Technique, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$161.8 ... Read More
-
Anemia Drugs
... at a CAGR of 4.1% over the analysis period 2023-2030. Iron Deficiency Anemia Drugs, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$7.4 Billion by the ... Read More
-
H1N1 Vaccines
... at a CAGR of 5.4% over the analysis period 2023-2030. Intramuscular Vaccines, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$1.1 Billion by the end of ... Read More
-
Lymphoma Therapeutics
... at a CAGR of 6.6% over the analysis period 2023-2030. Non-Hodgkin Lymphoma (NHL) Therapeutics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$20.5 Billion by the ... Read More
Research Assistance
